Modeling tau pathology in human stem cell derived neurons.

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Tau pathology is a hallmark of neurodegenerative diseases like Alzheimer's disease (AD) and Frontotemporal Dementia (FTD).
• Dysfunctional tau is implicated in neuronal death, making it a key therapeutic target.
• Tau pathology development precedes clinical symptoms, necessitating research into early molecular events.

Purpose of the Study:

• To review the progress and potential of using induced pluripotent stem cells (iPSCs) for studying tauopathies.
• To highlight challenges and unanswered questions in tauopathy research using iPSC-derived neurons.

Main Methods:

• Utilizing patient-derived induced pluripotent stem cells (iPSCs) to generate human neurons.
• In vitro studies of disease mechanisms with physiologically relevant gene expression.

Main Results:

• iPSCs provide a renewable source of human neurons modeling genetic tauopathies.
• This approach allows for in-depth investigation of early molecular events in tau pathology.

Conclusions:

• Patient-derived iPSCs are a valuable tool for understanding tauopathy pathogenesis.
• Further research using iPSCs can address critical questions and guide therapeutic development for AD and FTD.